Tradestie Institutional Equity Comparison Engine

COCP vs PRPO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PRPO Overall Edge

PRPO Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Precipio, Inc. Common Stock (PRPO) driven by superior Valuation, Growth & Margin while COCP counters with relative strength in Momentum & Technical. Fundamentally, COCP trades at N/M Forward P/E with -3063.6% operating margin (+26.9% YoY revenue) versus PRPO at 15.4x Forward P/E and -5.3% operating margin (+8.3% YoY). In options structure, COCP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PRPO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner PRPO
COCP N/M vs PRPO 15.4x Fwd P/E
Growth & Margin Winner PRPO
Op Margin -3063.6% vs -5.3% ยท YoY +26.9% vs +8.3%
Momentum & Technical Winner COCP
1Y -3.0% vs +1.9% ยท 52W Pos 19% vs 16%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
COCP NASDAQ
Cocrystal Pharma, Inc. Common Stock
Pharmaceutical Preparations
$1.00
+1.98% 1D
Market Cap $19.6M
1M Return -2.01%
1Y Return -2.96%
Forward P/E N/M
Unified AI Score
47.1 / 100 HOLD
Tech 51.0 Fund 48.0 Flow 50.0 Mom 54.0
PRPO NASDAQ
Precipio, Inc. Common Stock
Laboratory Analytical Instruments
$20.39
-7.86% 1D
Market Cap $40.2M
1M Return -4.61%
1Y Return +1.95%
Forward P/E 15.4x
Unified AI Score
32.2 / 100 SELL
Tech 5.0 Fund 31.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: COCP -2.96% PRPO +1.95% Spread: +7.42 pp (PRPO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
COCP TTM Op. Margin: -3063.6% PRPO TTM Op. Margin: -5.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on COCP vs PRPO. Trailing 12-month operating profitability (COCP -3063.6% vs PRPO -5.3%) and valuation multiples (COCP N/M vs PRPO 15.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: COCP (5) vs PRPO (5)
Institutional Metric COCP PRPO Criterion Row Winner
Market Capitalization Scale $19.6M $40.2M Larger Scale PRPO
Trailing P/E Ratio Valuation N/M 15.4x Lower Multiple PRPO
Forward P/E Ratio Valuation N/M 15.4x Lower Multiple PRPO
Revenue Growth (YoY) Growth +26.9% +8.3% Higher Growth COCP
Operating Margin (TTM) Profitability -3063.6% -5.3% Higher Margin PRPO
Net Profit Margin Profitability 0.0% -4.1% Higher Margin COCP
Return on Equity (ROE) Capital Efficiency -311.7% -8.0% Higher ROE PRPO
52-Week Range Position Momentum 19% ($1โ€“$2) 16% ($18โ€“$34) Stronger Trend COCP
Beta / 30D Volatility Risk Regime 1.04ฮฒ ยท 54% Vol 1.19ฮฒ ยท 95% Vol Lower Realized Risk COCP
Unified Institutional Score Composite Signal 47.1 / 100 (HOLD) 32.2 / 100 (SELL) Higher Composite COCP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full COCP vs PRPO Buy Guide
COCP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live COCP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PRPO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PRPO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither COCP nor PRPO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.